Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,683 | -19,627 | 5,643 | -116,835 | -75,040 |
| Depreciation Amortization | 14,017 | 9,297 | 4,569 | 18,523 | 13,341 |
| Accounts receivable | 48,305 | 47,929 | -13,464 | 2,252 | 499 |
| Accounts payable and accrued liabilities | -899 | -664 | -5,885 | -6,305 | -4,548 |
| Other Working Capital | 48,403 | 52,116 | -8,891 | 48,858 | -10,183 |
| Other Operating Activity | -44,107 | -60,186 | -5,287 | 28,761 | 11,468 |
| Operating Cash Flow | $23,036 | $28,865 | $-23,315 | $-24,746 | $-64,463 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -84,047 | -107,085 | -1,692 | -13,363 | 0 |
| PPE Investments | -2,033 | -1,256 | -218 | -1,073 | -797 |
| Net Acquisitions | N/A | N/A | N/A | 79 | 79 |
| Purchase Of Investment | N/A | -102 | -105 | 489 | N/A |
| Sale Of Investment | -3 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -65 | -37 | -37 | N/A | N/A |
| Other Investing Activity | -64 | -37 | -36 | -1,642 | -1,140 |
| Investing Cash Flow | $-86,147 | $-108,480 | $-2,051 | $-15,510 | $-1,858 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,317 | 16,207 | 16,251 | 29,671 | 28,282 |
| Debt Repayment | -3,954 | -2,621 | -1,315 | -5,107 | -3,831 |
| Common Stock Issued | 82,823 | 82,823 | N/A | 67,936 | 23,614 |
| Other Financing Activity | -8,998 | -6,003 | -3,040 | -9,635 | -6,780 |
| Financing Cash Flow | $86,188 | $90,406 | $11,896 | $82,865 | $41,285 |
| Exchange Rate Effect | -697 | 1,542 | -267 | 884 | -822 |
| Beginning Cash Position | 136,708 | 136,708 | 136,708 | 93,216 | 93,216 |
| End Cash Position | 159,087 | 149,042 | 122,971 | 136,708 | 67,358 |
| Net Cash Flow | $22,379 | $12,334 | $-13,737 | $43,492 | $-25,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,036 | 28,865 | -23,315 | -24,746 | -64,463 |
| Capital Expenditure | -2,033 | -1,256 | -218 | -1,073 | -797 |
| Free Cash Flow | 21,003 | 27,609 | -23,533 | -25,819 | -65,260 |